You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
Title |
Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospects
|
---|---|
Published in |
Frontiers in oncology, April 2024
|
DOI | 10.3389/fonc.2024.1397053 |
Pubmed ID | |
Authors |
Charles J Milrod, Ari Pelcovits, Thomas A Ollila |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 67% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2024.
All research outputs
#16,323,211
of 25,872,466 outputs
Outputs from Frontiers in oncology
#5,647
of 22,820 outputs
Outputs of similar age
#97,751
of 223,534 outputs
Outputs of similar age from Frontiers in oncology
#45
of 336 outputs
Altmetric has tracked 25,872,466 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,820 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 223,534 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 336 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.